🔎 Trials Near Me

Dachaigh › Ailseachadh an Ae (Carcinoma Hepatocellular) › Texas › Houston

Sgrùdaidhean clionaigeach Ailseachadh an Ae (Carcinoma Hepatocellular) ann an Houston, TX

Tha 31 sgrùdaidhean airson Ailseachadh an Ae (Carcinoma Hepatocellular) a’ lorg phàirtichean aig làraichean ann agus timcheall air Houston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study of ZW251 in Participants With Advanced Solid Tumors

A’ fastadhÌre 1
  • MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07164313

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

A’ fastadhÌre 1/2
  • Research Facility, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06726161

National Liver Cancer Screening Trial

A’ fastadhÌre 4
  • Baylor College of Medicine, Houston
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06084234

A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

A’ fastadhÌre 1/2
  • The University of Texas Md Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT06427941

Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer

A’ fastadhÌre 1/2
  • M D Anderson Cancer Center, Houston
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT04380545

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

A’ fastadhÌre 3
  • Research Site, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06921785

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

A’ fastadhÌre 1/2
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
12 Months – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04851119

FOG-001 in Locally Advanced or Metastatic Solid Tumors

A’ fastadhÌre 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT05919264

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

A’ fastadhÌre 1/2
  • Research Site, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Lùna 2026 · NCT06795022

A Study of MGC026 in Participants With Advanced Solid Tumors

A’ fastadhÌre 1
  • The University of Texas MD Anderson Cancer Center, Houston
  • University of Texas Health Science Center at Houston, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT06242470

IDOV-Immune for Advanced Solid Tumors

A’ fastadhÌre 1
  • MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT06910657

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

A’ fastadhÌre 2
  • University of Texas MD Anderson Cancer Center, Houston
Aoisean 8 agus nas sine · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT05503797

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

A’ fastadhÌre 1
  • The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
  • The University of Texas MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT05208762

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

A’ fastadhÌre 1
  • M D Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Iuch 2026 · NCT05092373

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

A’ fastadhÌre 1
  • Clinical Trial Site, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT06600321

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

A’ fastadh
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT05486572

A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma

A’ fastadhÌre 1
  • The University of Texas M. D. Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Ògmh 2026 · NCT07116486

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

A’ fastadhÌre 1
  • The University of Texas MD Anderson Cancer Center, Houston
Aoisean 16 agus nas sine · Gach gnè · Air ùrachadh 2 Ògmh 2026 · NCT07197554

Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy

A’ fastadhÌre 2
  • M D Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Cèit 2026 · NCT04982653

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

A’ fastadh
  • M D Anderson Cancer Center, Houston
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT05053555

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

A’ fastadhÌre 2
  • USA12-0, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT06953089

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

A’ fastadhÌre 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Gibl 2026 · NCT05440708

Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • M D Anderson Cancer Center, Houston
Gach aois · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT05143619

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

A’ fastadhÌre 1/2
  • MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT06362369

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

A’ fastadhÌre 2
  • Houston Methodist Hospital Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Gibl 2026 · NCT05733598

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

A’ fastadhÌre 2
  • Baylor College of Medicine, Houston
Aoisean 0 gu 30 · Gach gnè · Air ùrachadh 24 Gearr 2026 · NCT04134559

Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)

A’ fastadhÌre 2
  • Houston Methodist Neal Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Samh 2025 · NCT06698250

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

A’ fastadhÌre 1
  • Houston Methodist Hospital, Houston
Suas gu aois 21 · Gach gnè · Air ùrachadh 3 Samh 2025 · NCT06198296

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

A’ fastadhSgrùdadh amharc
  • Massive Bio SYNERGY-AI site, Houston
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria

A’ fastadhÌre 4
  • Houston Methodist Research Institute, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Gearr 2023 · NCT05185505

Sgrùdaidhean Ailseachadh an Ae (Carcinoma Hepatocellular) ann am bailtean eile

Sgrùdaidhean eile ann an Houston

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.